125 related articles for article (PubMed ID: 37983632)
1. The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan: A multicenter collaborative observational study.
Murai K; Hikita H; Kodama T; Kaibori M; Nishimura Y; Tatsumi T; Yamada T; Kanto T; Mochida S; Takehara T
Hepatol Res; 2024 May; 54(5):439-450. PubMed ID: 37983632
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
Amaddeo G; Brustia R; Allaire M; Lequoy M; Hollande C; Regnault H; Blaise L; Ganne-Carrié N; Séror O; Larrey E; Lim C; Scatton O; El Mouhadi S; Ozenne V; Paye F; Balladur P; Dohan A; Massault PP; Pol S; Dioguardi Burgio M; Vilgrain V; Sepulveda A; Cauchy F; Luciani A; Sommacale D; Leroy V; Roudot-Thoraval F; Bouattour M; Nault JC;
JHEP Rep; 2021 Feb; 3(1):100199. PubMed ID: 33163949
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study.
Gandhi M; Ling WH; Chen CH; Lee JH; Kudo M; Chanwat R; Strasser SI; Xu Z; Lai SH; Chow PK
J Hepatocell Carcinoma; 2021; 8():1159-1167. PubMed ID: 34589445
[TBL] [Abstract][Full Text] [Related]
4. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study.
Bilican G; Özgül S; Ekmen N; Moral K; Küçük H; Dumanlı S; Abiyev A; Karakan T; Kekilli M
J Gastrointestin Liver Dis; 2023 Sep; 32(3):367-370. PubMed ID: 37774229
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma.
Rao A; Rich NE; Marrero JA; Yopp AC; Singal AG
J Natl Compr Canc Netw; 2021 May; 19(9):1063-1071. PubMed ID: 34077908
[TBL] [Abstract][Full Text] [Related]
6. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL).
Okushin K; Tateishi R; Hirakawa S; Tachimori H; Uchino K; Nakagomi R; Yamada T; Nakatsuka T; Minami T; Sato M; Fujishiro M; Hasegawa K; Eguchi Y; Kanto T; Yoshiji H; Izumi N; Kudo M; Koike K
Sci Rep; 2024 Feb; 14(1):2826. PubMed ID: 38310156
[TBL] [Abstract][Full Text] [Related]
7. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
[TBL] [Abstract][Full Text] [Related]
8. Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan.
Kudo M
Liver Cancer; 2015 Mar; 4(1):39-50. PubMed ID: 26020028
[TBL] [Abstract][Full Text] [Related]
9. B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial.
Kudo M; Ueshima K; Osaki Y; Hirooka M; Imai Y; Aso K; Numata K; Kitano M; Kumada T; Izumi N; Sumino Y; Ogawa C; Akazawa K
Liver Cancer; 2019 Jul; 8(4):271-280. PubMed ID: 31602370
[TBL] [Abstract][Full Text] [Related]
10. Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States.
Lee IS; Okumura K; Misawa R; Sogawa H; Veillette G; John D; Diflo T; Nishida S; Dhand A
World J Hepatol; 2023 Apr; 15(4):554-563. PubMed ID: 37206654
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.
De Souza S; Kahol de Jong J; Perone Y; Shetty S; Qurashi M; Vithayathil M; Shah T; Ross P; Temperley L; Yip VS; Banerjee A; Bettinger D; Sturm L; Reeves HL; Geh D; Orr J; Allen B; Jones RP; Sharma R
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444488
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
14. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC.
Yin X; Hua T; Liang C; Chen Z
Transl Cancer Res; 2019 Aug; 8(4):1035-1045. PubMed ID: 35116847
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and liver cancer: lost patients and larger tumours.
Geh D; Watson R; Sen G; French JJ; Hammond J; Turner P; Hoare T; Anderson K; McNeil M; McPherson S; Masson S; Dyson J; Donnelly M; MacDougal L; Patel P; Hudson M; Anstee QM; White S; Robinson S; Pandanaboyana S; Walker L; McCain M; Bury Y; Raman S; Burt A; Parkinson D; Haugk B; Darne A; Wadd N; Asghar S; Mariappan L; Margetts J; Stenberg B; Scott J; Littler P; Manas DM; Reeves HL
BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35450934
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan.
Ohira H; Abe K; Takahashi A; Zeniya M; Ichida T
J Gastroenterol; 2013 Jan; 48(1):109-14. PubMed ID: 22688407
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
[TBL] [Abstract][Full Text] [Related]
19. Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Han JE; Cho HJ; Cheong JY; Lim SG; Yang MJ; Noh CK; Lee GH; Kim SS
World J Gastroenterol; 2023 Dec; 29(47):6122-6137. PubMed ID: 38186683
[TBL] [Abstract][Full Text] [Related]
20. Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
Kudo M; Lencioni R; Marrero JA; Venook AP; Bronowicki JP; Chen XP; Dagher L; Furuse J; Geschwind JF; Ladrón de Guevara L; Papandreou C; Sanyal AJ; Takayama T; Yoon SK; Nakajima K; Lehr R; Heldner S; Ye SL
Liver Int; 2016 Aug; 36(8):1196-205. PubMed ID: 26901163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]